» Articles » PMID: 32365569

Functional Implications of Cathelicidin Antimicrobial Protein in Breast Cancer and Tumor-Associated Macrophage Microenvironment

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 May 6
PMID 32365569
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

It is well-established that tumor-associated macrophages (TAMs) play an important role in breast cancer development. Accumulating evidence suggested that human cathelicidin antimicrobial protein (), which is mainly expressed in host defense cells such as macrophages, is crucial not only in combating microorganisms but also promoting tumor growth. Here we report the interaction of with TAMs in breast cancer. expression was upregulated in cancer tissues and in the circulation of breast cancer patients. Surgical removal of tumor decreased CAMP peptide serum level. Knockdown of decreased cell proliferation and migration/invasion ability in breast cancer cells. expression was altered during macrophage M1/M2 polarization and was expressed predominantly in M2 phenotype. In addition, breast cancer cells co-cultured with macrophages upregulated expression and also increased cancer cell viability. Xenograft tumors reduced significantly upon receptor antagonist treatment. Our data implicated that confers an oncogenic role in breast cancer and plays an important role in the tumor microenvironment between TAMs and breast cancer cells, and blocking the interaction between them would provide a novel therapeutic option for this malignant disease.

Citing Articles

Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison.

Kim Y, Kim J, Song Y, Jang K, Kim S, Kim H Front Vet Sci. 2025; 11:1473421.

PMID: 39911484 PMC: 11795822. DOI: 10.3389/fvets.2024.1473421.


Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection.

Hu Y, Paris S, Sahoo N, Bertolet G, Wang Q, Wang Q JCI Insight. 2023; 8(12).

PMID: 37345658 PMC: 10371249. DOI: 10.1172/jci.insight.167749.


A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer.

Lin Y, Zhang R, Pan H, Li Y Med Sci Monit. 2023; 29:e938660.

PMID: 36973995 PMC: 10066621. DOI: 10.12659/MSM.938660.


Neutrophils in cancer carcinogenesis and metastasis.

Xiong S, Dong L, Cheng L J Hematol Oncol. 2021; 14(1):173.

PMID: 34674757 PMC: 8529570. DOI: 10.1186/s13045-021-01187-y.


Antimicrobial peptides: mechanism of action, activity and clinical potential.

Zhang Q, Yan Z, Meng Y, Hong X, Shao G, Ma J Mil Med Res. 2021; 8(1):48.

PMID: 34496967 PMC: 8425997. DOI: 10.1186/s40779-021-00343-2.


References
1.
Brown K, Poon G, Birkenhead D, Pena O, Falsafi R, Dahlgren C . Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J Immunol. 2011; 186(9):5497-505. DOI: 10.4049/jimmunol.1002508. View

2.
Beatty G, Chiorean E, Fishman M, Saboury B, Teitelbaum U, Sun W . CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. 2011; 331(6024):1612-6. PMC: 3406187. DOI: 10.1126/science.1198443. View

3.
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

4.
Reinholz M, Ruzicka T, Schauber J . Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol. 2012; 24(2):126-35. PMC: 3346901. DOI: 10.5021/ad.2012.24.2.126. View

5.
Chen X, Zou X, Qi G, Tang Y, Guo Y, Si J . Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer. Cell Physiol Biochem. 2018; 47(3):1060-1073. DOI: 10.1159/000490183. View